Aarti Pharma Labs Bolsters Leadership with Two Key Senior Management Appointments
Aarti Pharma Labs Limited has announced two significant appointments to its senior management team, effective November 10, 2025. Mr. Hemant Gundare, with a doctorate in Green Chemistry, joins as Head Corporate - EHS (Environment, Health & Safety). Mr. Shrihari S. Mane, with 32 years of experience in API manufacturing, has been appointed as Chief Technology Officer (API). These appointments, approved by the Board of Directors on November 9, 2025, aim to enhance the company's environmental sustainability, safety practices, and technological capabilities in API manufacturing.
*this image is generated using AI for illustrative purposes only.
Aarti Pharma Labs Limited , a prominent player in the pharmaceutical industry, has announced significant additions to its senior management team, effective November 10, 2025. The company's Board of Directors, following recommendations from the Nomination and Remuneration Committee, approved these appointments during their meeting on November 9, 2025.
New Appointments
| Position | Appointee | Expertise |
|---|---|---|
| Head Corporate - EHS (Environment, Health & Safety) | Mr. Hemant Gundare | Environmental health and safety management, Doctorate in Green Chemistry |
| Chief Technology Officer (API) | Mr. Shrihari S. Mane | 32 years of experience in API manufacturing, Flow Chemistry, PAT tool application, large scale operations, and strategic leadership in peptides and Oncology areas |
Strengthening Environmental and Technological Capabilities
The appointment of Dr. Hemant Gundare as Head Corporate - EHS underscores Aarti Pharma Labs' commitment to environmental sustainability and safety. With his doctorate in Green Chemistry, Dr. Gundare brings valuable expertise to the company's environmental health and safety management practices.
Mr. Shrihari S. Mane's appointment as Chief Technology Officer (API) is expected to enhance the company's technological capabilities. His extensive experience in API manufacturing and strategic leadership in emerging areas like peptides and Oncology aligns with the evolving landscape of pharmaceutical research and development.
Potential Impact
These strategic appointments may contribute to Aarti Pharma Labs' growth and operational excellence in the competitive pharmaceutical sector. The company's approach in strengthening its leadership team demonstrates its focus on innovation, safety, and sustainable practices in pharmaceutical manufacturing.
Industry observers may watch closely to see how these new additions to the senior management team could influence Aarti Pharma Labs' future strategies and market position in the pharmaceutical industry.
Historical Stock Returns for Aarti Pharma Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.22% | +3.28% | -14.34% | -22.35% | +10.47% | +150.98% |
20
